Equity-Based Compensation |
9 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | ||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||
| Equity-Based Compensation | 4. Equity-Based Compensation We granted 2,490 and 99,649 restricted stock units (RSUs) during the three months ended September 30, 2026 and 2025, respectively, and granted 840,043 and 594,983 RSUs during the nine months ended September 30, 2026 and 2025, respectively. Equity-based compensation expense related to RSUs was $34.2 million and $27.6 million during the three months ended September 30, 2026 and 2025, respectively, and $90.1 million and $80.7 million during the nine months ended September 30, 2026 and 2025, respectively. We present below a summary of changes during the nine months ended September 30, 2026 in our unvested restricted stock units:
|
|||||||||||||||||||||||||||||||||||